Τόμος 12 (1994) – Τεύχος 1 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 12 (1994) – Issue 1 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Γεώργιος Ν. Καραχάλιος

Γ’ Παθολογικό Τμήμα του Νοσοκομείου του Ελληνικού Ερυθρού Σταυρού, Αθήνα

George Karachalios

Red Cross Hospital

1. Kass, E.H., Finland, M.: Corticosteroids and infec­tions. Adv. Intern. Med. 9: 45-80 (1958)
2. Beisel, W.R., Rapopport, M.I.: Inter-relations be­tween adrenocortical functions and infections ill­nesses. N. Engl. J. Med. 280: 541-546 and 596-604 (1969)
3. Truhan, A.P., Ahmed, A.R.: Corticosteroids: A review with emphasis on complications of prolonged systemic therapy. Ann. Allergy 62: 375-391 (1989)
4. Munk, A., Mendel, D.B., Smith, L.I., Orti, E.: Glu­cocorticoid receptors and actions. Am. Rev. Respir. Dis. 14 (Suppl.): 2-10 (1990)
5. Bouchard, P., Kutten, F., Nahoul, K., Mavier, P., Schaison, G., Manvais-Jarvis, P.: Deviation du me­tabolisme du cortisol, induite par la rifampicine. Con­sequences therapeutiques au cours de l’ insuffisance surrenalienne. Nouv. Presse Med. 8: 1651-1653 (1979)
6. Bishop, C.R., Athens, J.W., Bogg, D.R.: Leucoki­netic studies. XIII: A non-steady state kinetic evalu­ation of the mechanism of cortisone induced granu­locytosis. J. Clin. Invest. 47: 249-260 (1968)
7. Parillo, J.E., Fanci, A.S.: Mechanisms of glucocor­ticoid action on immune processes. Ann. Rev. Phar­macol. Toxicol. 19: 179-186 (1979)
8. Mandell, G.L., Rubin, W., Hook, E.W.: The effect of NADH oxidase inhibitor (hydrocortisone) on poly­morphonuclear leukocyte bacterial activity. J. Clin. Invest. 409: 1381-1388 (1970)
9. Miller, D.R., Kaplan, F.M.: Decreased nitroblue tetrazolium dye reduction in the phagocytes of pa­tients receiving prednisone. Pediatrics 45: 861-865 (1970)
10. Persellin, R.H., Ku, L.C.: Effects of steroids hor­mones on human polymorphonuclear leukocyte ly­sosomes. J. Clin. Invest. 54: 919-925 (1974)
11. Dillard, G.M., Bodel, P.: Studies on steroid fever. I: Pyrogenic and antipyrogenic activity in vitro of some endogenous steroids in man. J. Clin. Invest. 49: 2418-2423 (1970)
12. Clauman. H.N.: Corticosteroids and lymphoid cells. N. Engl. J. Med. 287: 388-393 (1972)
13. Thompson, J., VanFurth, R.: The effect of gluco­corticosteroids on the kinetics of mononuclear phagocytes. J. Exper. Med. 131: 429-442 (1970)
14. Rhinehart, J.J., Sagone, Al., Balcerzak, S.P.: Ef­fects of corticosteroid therapy on human monocyte function. N. Engl. J. Med. 292: 236-239 (1975)
15. Cupps, T.R., Fanci., A.S.: Corticosteroid-medi­ated immunoregulation in man. Immunol. Rev. : 133-155 (1982)
16. Frey, T.R., Frey, B.M., Greither, A., Benet, L.Z.: Prednisolone clearance at steady state in dogs. J. Pharmacol. Exp. Ther. 21: 287-291 (1980)
17. Rocci, M.L.,Jr, Jonhson, N.F., Jusko, W.J.: Se­rum protein binding of prednisolone in four species. J. Pharm. Sci. 69: 977-980 (1980)
18. Stuck, A.E., Minder, Ch., Frey, F.J.: Risk of in­fections complications in patients taking glucocorti­costeroids. Rev. Infect. Dis. 11: 954-963 (1989)
19. Staples, P.J., Gerding, D.N., Decker, J.L.: Inci­dence of infections in systemic lupus erythematosus. Arthritis Rheum. 17: 1-5 (1974)
20. Myerowitz, R.L., Medeiros, A.A., O’Brien, T.F.: Bacterial infections in renal homotransplant recipi­ents. Am. J. Med. 53: 308-312 (1972)
21. Burry, H.G.: Bacteriuria in rheumatoid arthritis. Ann. Rheum. Dis. 47: 82-84 (1973)
22. McAllen, M.K., Kochawoski, S.J., Shaw, K.M.: Steroid aerosols in asthma: An assessment of betamethasone valerate and a 12-month study of pa­tients on maintenance treatment. Br. Med. 1: 717-719 (1974)
23. Toogood, J.H.: Complications of topical steroid therapy for asthma. Am. Rev. Respir. Dis. 141: 589-596 (1990)
24. Dale, D.C., Fanci, A.S., Wolff, S.M.: Daily and alternate – day prednisone: Granulocyte kinetics and susceptibility to infections. Clin. Res. 22: 439A (1974)
25. Frey, F.J.: Kinetics and dynamics of predni­solone. Endocr. Rev. 8: 453-473 (1987)
26. Harris, H.W.: Mycobacterial infections. In: Infec­tions in the Abnormal Host (M.H. Griego, ed.) pp. 360-381, Yorke Medical Books, 1980
27. Hsu, H.S.: Cellular basis cortisone-induced host susceptibility to tuberculosis. Am. Rev. Respir. Dis. 100: 677-680 (1969)
28. Editorial: Tuberculosis n corticosteroid-treated asthmatic patients. Br. Med. J. 3: 266-267 (1976)
29. Dale, D.C., Petersdorf, R.G.: Corticosteroids and infections diseases. Med. Clin. North Am. 57: 1277-1287 (1973)
30. Balk, R.A.: Treatment of sepsis and septic shock. Hosp. Phys. June: 18-34 (1992)
31. Bennett, L., Finland, F., Mamburger, M.: The ef­fectiveness of hydrocortisone in the management of severe infections. J.A.M.A. 183: 462-465 (1963)
32. Klatersky, J., Cappel, R., Derbuscher, L.: Effec­tiveness of betamethasone in management of severe infections: A double-blind study. N. Engl. J. Med. 284: 1248-1250 (1971)
33. Mitor, I.G., Terziski, D.G.: Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipids A of bacterial lipopolysaccharides. Infection 19: 383-390 (1991)
34. Packard, B.D., Weiler, J.M.: Steroids inhibit acti­vation of the alternative-amplification pathway of complement. Infect. Immun. 40: 1011-1015 (1983)
35. Kalin, N.H., Risch, S.C., Cohen, R.M., Insel, T., Murphy, T.: Dexamethasone fails to suppress beta-endorphin plasma concentrations in humans and rhesus monkeys. Science 209: 827-828 (1980)
36. Dinarello, C.H.: The proinflammatory cytocines interleukin-1 and tumor necrosis factor ant treatment of septic shock syndrome. J. Infect. Dis. 163: 1177-1184 (1991)
37. Old, L.J.: Tumor necrosis factor. Another chap­ter in the long history of endotoxin. Science 330: 602-603 (1987)
38. Skubitz, K.M., Craddock, P.R., Hammerschmidt, D.E.: Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocytes aggregates in vitro. J. Clin. Invest. 688: 13-18 (1981)
39. Gehr, G., Braum, T., Lesslauer, W.: Cytocines, receptors and inhibitors. Clin. Invest. 70: 64-69 (1992)
40. Sheagren, J.N.: Corticosteroids for the treatment of septic shock. Infect. Dis. North Am. 5: 875-882 (1991)
41. Spink, W.W.: Host-parasite relationship in tuber­culosis. Lancet 2: 161-163 (1964)
42. Hayward, R.S.A., Steinberg, E.P., Ford, D.E., Roizen, M.F., Roach, K.W.: Preventive care guide­lines 1991. Ann. Intern. Med. 114: 758-783 (1991)
43. Schumer, W.: Steroids in the treatment of clinical septic shock. Ann. Surg. 184: 333-339 (1976)
44. Sprung, C.L., Cardlis, P.V., Marcial, E.H., Pierce, M., Gelbard, M.A., Long, W.M., Duncan, R.C., Tendler, M.D., Karp, F.M.: The effects of high dose corticosteroids in patients with septic shock. A pro­spective, controlled study. N. Engl. J. Med. 311: 1137-1143 (1984)
45. Bone, R.C., Fisher, C.J., Jr, Clemmer, T.P., Slotman, G.J., Metz, C.A., Balk, R.A.: The Methyl­prednisolone Severe Sepsis Study Group. A con­trolled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317: 653-658 (1987)
46. Veterans Administration Systemic Sepsis Coop­erative Study Group: Effects of high-dose glucocorti­coid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317: 658-665 (1987)
47. Chesney, P.J.: Clinical aspects and spectrum of illness of toxic shock syndrome: Overview. Rev. In­fect. Dis. 11(Suppl 1): 51-57 (1989)
48. Καραχάλιος, Γ.Ν.: Συνδρομο τοξικού shock. Mat. Med. Greca 9: 591-592 (1981)
49. Reingold, A.L., Hargrett, N.T., Dan, B.D., Shands, K.N., Strickland, B.Y., Broume, C.V.: Non­mstreual toxic shock syndrome. Ann. Intern. Med. 96: 871-874 ( 1982)
50. MacDonald, K.L., Osterholm, M.T., Hedberg, C.W., Shrock, C.G., Peterson, G.F., Jentzen, J.M., Leonard, S.A., Schievert, P.M.: Toxic shock syn­drome: a newly recognized complication of influenza and influenza-like illness. J.A.M.A. 257: 1053-1058 (1987)
51. Todd, J.K., Reesman, M., Caston, S.A., Todd, B.H., Wiesenthal, A.M.: Corticosteroid therapy for patients with toxic shock syndrome. J.A.M.A. 252: 2399-2402 (1984)
52. Anonymous: Follow-up on toxic shock syndrome. Morb. Mortal. Weekly Rep. 29: 441-445 (1980)
53. Erstad, B.L., Witte, C.L., Talkington, D.F.: Toxic-shock-like syndrome. Pharmacotherapy 12: 23-27 (1992)
54. Hoffman. S.L., Punjabi, N.H., Kumala, S., Moech­tar, A., Pulungsih, S.P., Rivai, A.R., Rockhill, R.C., Woodward, T.E., Loedin, A.A.: Reduction of mortal­ity in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N. Engl. J. Med. 310: 82-88 (1984)
55. McGowan, J.E., Chesney, P.J., Crossley, K.B., La Force, F.M.: Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J. Infect. Ds. 165: 1-13 (1992)
56. Johnson, J.R., Taylor, B.C., Morissey, J.F.: Cor­ticosteroids in pulmonary tuberculosis. Am. Rev. Re­sp. Dis. 92: 376 (1965)
57. Lorber, J.: Treatment of tuberculous meningitis. Br. Med. J. 1: 1309-1312 (1960)
58. Voljavec, B.F., Corpe, R.F.: The influence of corticosteroid hormone in the treatment of tubercu­lous meningitis in negroes. Am. Rev. Resp. Dis. 81: 539-545 (1960)
59. Wasz-Hockert, I.: Late prognosis in tuberculous meningitis. Acta Paediatr. Scand. 51 (Suppl. 141): 1-119 (1962)
60. Smith, H.: Tuberculous meningitis. Int. J. Neurol. 4: 134-157 (1964)
61. Hockaday, J.M., Smith, H.V.: Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis. Tubercle 47: 75-91 (1966)
62. Horne, N.W.: A critical evaluation of corticoster­oids in tuberculosis. Adv. Tuberc. Res. 15: 1-54 (1966)
63. O’Toole, R.D., Thornton, G.F., Mukjherjee, M.K., Nath, R.L.: Dexamethasone in tuberculous meningi­tis: relationship of CSF effects and therapeutic effi­cacy. Ann. Intern. Med. 70: 39-48 (1969)
64. Escobar, J.A., Belsey, M.A., Duenas, A.: Mortal­ity from tuberculous meningitis reduced steroid ther­apy. Pediatrics 56: 105101055 (1975)
65. Molavi, A., LeFrock, J.C.: Tuberculous meningi­tis. Med. Clin. North Am. 69: 315-331 (1985)
66. Leonard, J.M., Des Prez, R.M.: Tuberculous meningitis. Infect. Dis. Clin. North Am. 4: 762-787 (1990)
67. Allen, M.B., Cooke, N.J.: Corticosteroids and tu­berculosis. Br. Med. J. 303: 871-872 (1991)
68. Parsons, M.: The treatment of tuberculous men­ingitis. Tubercle 70: 79-82 (1989)
69. Strang, J.I.G., Kakaza, H.H.S., Gibson, D.G., Allen, B.W., Mitchison, D.A., Evans, D.J., Girling, D.J., Nunn, A.J.: Controlled clinical trial of complete open surgical drainage and of prednisolone in treat­ment of tuberculous pericardial effusion in Transkei. Lancet 2: 759-764 (1988)
70. Rooney, J.J., Crocco, J.A., Lyons, H.A.: Tuber­culous pericarditis. Ann. Intern. Med. 72: 73-78 (1970)
71. Nemir, R.L., Cardona, J., Vaziri, F., Toledo, R.: Prednisolone as an adjunct in chemotherapy of lymph node – bronchial tuberculosis in childhood: a double blind study. II Further term studies. Am. Rev. Respir. Dis. 95: 402-410 (1967)
72. Epstein, D.M.: Tuberculous pleural effusions. Chest 91: 106-110 (1987)
73. Lee, C.H.: Corticosteroids in the treatment of tu­berculous pleurisy. A double-blind, placebo-con­trolled, randomized study. Chest 94: 1256 (1988)
74. Klimach, O.E., Ormerod, L.P.: Gastrointestinal tuberculosis: a retrospective review of 109 cases n a district general hospital. Q. J. Med. 56: 569-578 (1985)
75. Bestani, B., Shariaztadeh, M.R., Dehdashti, F.: Tuberculosis peritonitis – Report of 30 cases and re­view of literature. Q. J. Med. 56: 549-557 (1985)
76. Zeller, F.: Corticosteroidtherapie der striktu­rievender Harnleiter-Tbc. Verhandlungsbericht, Tagung Deutschen Gesellschaft fr Urologie 22: 45-47 (1969)
77. Okilacany, O., Skutil, V., Payer, J.: Glukokor­tikoide in der Behandlung der Tuberkulose der Harn­wege. Urol. Int. 16: 138-170 (1963)
78. Zeller, F.N., Rothauge, C.F.: Ergebnisse der konservativen Behandlung der Nierentuberkulose. Therapiewoche 22/37: 3068-3074 (1972)
79. Horne, N.W., Tulloch, W.S.: Conservative man­agement of renal tuberculosis. Br. J. Urol. 47: 481-487 (1975)
80. Lester, T.W.: Extrapulmonary tuberculosis. Clin. Chest Med. 1: 219-225 (1980)
81. Masud, T., Kemp, E.: Corticosteroids in treatment of disseminated tuberculosis in patient with HIV in­fection. Br. Med. J. 296: 464-465 (1988)
82. Καραχάλιος, Γ.Ν., Χατζηπέτρου, .Σ., Καραμπέτσος, Α.Κ.: Μικροβιακή μυνιγγίτις και δεξαμεθαζόνη: Πρέπει να χορηγείται ή όχι; Ιατρικά Χρονικά 15: 133-137 (1992)
83. Lebel, M.H., Freig, B.J., Syrogiannopoulos, G.A., Chrane, D.F., Hoyt, M.J., Stewart, S.M., Kennard, B.D., Olsen, K.D., McCracken, G.H.,Jr: Dex­amethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N. Engl. J. Med. 319: 964-971 (1988)
84. Lebel, M.H., Hyot, J., Waagner, D.C., Rollins, N.K., Finitzo, T., McCracken, G.H.,Jr,: Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am. Dis. Childr. 143: 301-306 (1989)
85. Girgis, N.I., Farid, Z., Mikhai, I.A., Farrag, I., Sul­tan, Y., Kilpatric, M.E.: Dexamethasone therapy for bacterial meningitis in children and adults. Pediatr. In­fect. Dis. J. 8: 848-851 (1989)
86. Odio, C., Faingeziht, I., Paris, M., Nassar, M., Baltodano, A., Rogers, J., Saez-Leorens, X., Olsen, K.D., McCracken, G.H.: The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 324: 1525-1531 (1991)
87. Dinarello, C.A.: The proinflammatory cytocines interleukin-1 and tumor necrosis factor and treatment of septic shock syndrome. J. Infect. Dis. 163: 1177-1184 (1991)
88. Ho, D.D., Hirsch, M.S.: Acute viral encephalitis. Med. Clin. North Am. 69: 415-419 (1985)
89. Appelbaum, E., Abder, C.: Treatment of measles encephalitis with corticotropin. Am. Dis. Child. 92: 147-151 (1956)
90. Allen, J.E.: Treatment of measles encephalitis with adrenal steroids. Pediatrics 20: 87-91 (1957)
91. Hoke, C.H.,Jr, Vaugh, D.W., Nisalak, A., Intra­lawan, P., Poolsuppasit, S., Jongsawas, V., Titsyakorn, U., Johnson, R.: Effect of high-dose dexamethasone on the out come of acute encephali­tis due to Japanese encephalitis virus. J. Infect. Dis. 163: 631-637 (1992)
92. Elliott, F.A.: Treatment of herpes foster with a high dose of prednisone. Lancet 2: 610-611 (1964)
93. Elliott, F.A.: Posttherapeutic neuralgia. Br. Med. J. 1: 679 (1973)
94. Epstein, E.: Treatment of zoster and postzoster neuralgia by the intralesional injection of triam­cinolone: A computer analysis of 199 cases. Int. J. Dermatol. 15: 762-769 (1976)
95. Eaglstein, W.H., Katz, R., Brown, J.A.: The eff­ects of early corticosteroids therapy on the skin eruption and pain of herpes zoster. J.A.M.A. 211: 1681-1683 (1970)
96. Keczkes, K., Basheer, A.M.: Do corticoids pre­vent post-herpetic neuralgia? Br. J. Dermatol. 102: 551-555 (1980)
97. Clemmensen, O.J., Andersen, K.E.: ACTH ver­sus prednisone and placebo in herpes zoster treat­ment. Clin. Exp. Dermatol. 9: 557-563 (1984)
98. Esmann, V., Kroon, S., Peterslund, N.A., Ronne-Rasmussen, J.O., Geil, J.P., Fogh, H., Petersen, C.S., Danielsen, L.: Prednisolone does not prevent post-herpetic neuralgia. Lancet 2: 126-129 (1987)
99. Anderson, D.J., Janoff, E.N.: Herpes zoster in­fection in a patient on methotrexate given prednisone to prevent post herpetic neuralgia. Ann. Intern. Med. 103: 783 (1987)
100. Collins, M., Fleisher, G., Kreisberg, J., Fager, S.: The role of steroids in the treatment of infections mononucleosis in the ambulatory college student. J. Am. Coll. Health 30: 101-103 (1984)
101. Brandforbrener, A., Epstein, A., Wu, S., Phair, J.: Corticosteroid therapy in Epstein-Barr virus infec­tion. Arch. Intern. Med. 146: 337-340 (1986)
102. Paydas, S., Akoglu, T.F., Akkiz, H., Ozer, F.L., Burgut, R.: Mortality-lowering of systemic corti­costeroid therapy in severe tetanus. Clin. Ther. 10: 276-280 (1988)
103. Moser, R.H.: Trichinosis: From Bismarck to po­lar bears. J.A.M.A. 228: 735-737 (1974)
104. Kasper, D.L., Kass, E.H.: Infections diseases rounds: headache, fever and periorbital edema. Rev. Infect. Dis. 9: 804-809 (1988)
105. Del Brutto, O.H., Sotelo, J.: Neurocysticercosis: An update. Rev. Infect. Dis. 10: 1075-1087 (1988)
106. Moodley, M., Moosa, A.: Treatment of neuro­cysticercosis: Is praziquantel the new hopes? Lancet 1: 262-263 (1989)
107. Kundson, G.B.: Treatment of anthrax in man: History and current concepts. Milit. Med. 151: 171-174 (1986)
108. Gersony, W.M.: Diagnosis and management of Kawasaki disease. J.A.M.A. 265: 2699-2703 (1991)
109. Cosgriff, T.M. (ed.): International Symposium on Hemostatic impairment Associated with Hemorrhagic Fever Viruses. Rev. Infect. Dis. 11(Suppl. 4): S669-S896 (1989)
110. Antoniadis, A., Le Duc, J.W., Acritidis, N., Alexiou-Daniel, S., Kyparissi, A., Saviolakis, G.A.: Hemorrhagic fever with renal syndrome in Greece. Clinical and laboratory characteristics of the disease. Rev. Infect. Ds. 11(Suppl. 4): S891-S896 (1989)
111. Qian, D., Ding, V., Chen, G., Ding, J., Chen, V., Lu, T., Wang, Z., Smego, R.A.,Jr: A placebo-con­trolled clinical trial of prednisone in the treatment of early hemorrhagic fever. J. Infect. Dis. 162: 1213-1214 (1990)
112. Hoffman, S.L., Rustama, D., Punjabi, N.H., Surampaet, B., Sanjaya, B., Dimpudus, A.J., McKee, K.T.,Jr, Paleologo, F.D., Campbell, J.R., Marwoto, H., Laughiin, L.: High-dose dexamethasone in qui­ninetreated patients with cerebral malaria: A double-blind, placebo-controlled trial. J. Infect. Dis. 158: 325-331 (1988)
113. Steere, A.G., Batsford, W.P., Weinberg, M.: Lyme carditis: cardiac abnormalities of Lyme dis­ease. Ann. Intern. Med. 93: 8-16 (1980)
114. Stecenko, M.A.: treatment of viral bronchiolitis: Do steroids make sense? Contemp. Pediatr. 4: 121 (1987)
115. Springer, C., Bar-Yishay, E., Uwayyed, K., Avi­tal, A., Vilonzi, D., Codfrey, S.: Corticosteroids do not affect the clinical or physiological status of infants with bronciolitis. Pediatr. Pulmonol. 9: 181-185 (1990)
116. Smith, D.S.: Corticosteroids in croup: A chink in the ivory tower? J. Pediatr. 115: 256-257 (1989)
117. Kairys, S.W., Olmstead, E.M., O’Connor, G.T. Steroid treatment of laryngotracheitis: A meta-analy­sis of the evidence from randomized trials. Pedist. 83: 683-693 (1989)
118. Skolnik, N.S.: Treatment of croup: a critical re­view. Am. J. Dis. Child 143: 1045-1049 (1989)
119. Super, D.M., Cartelli, N.A., Brooks, L.J., Lempo, R.M., Kumar, M.L.: A prospective randomized dou­ble-blind study to evaluate the effect of dex­amethasone in acute laryngotracheitis. J. Pediatr. 115: 323-329 (1989)
120. Newth, C.J.L., Lavison, H.: Diagnosing and managing croup and epiglotitis. J. Resp. Dis. 2: 22-30 (1981)
121. Ramsey, P.G., Weymuller, E.A.: Complications of bacterial infection of the ears, paranasal sinuses and oropharynx in adults. Emerg. Med. Clin. North Am. 3: 143-160 (1983)
122. Heinig, J.H., Weeke, E.R., Groth, S., Schwartz, B.: High-dose local steroid treatment in bronchopul­monary aspergiliosis: a pilot study. Allergy 43: 24-31 (1988)
123. Richeson, R.B., Stander, P.E.: Allergic bron­chopulmonary aspergiliosis. An increasingly common disorder among asthmatic patients. Postgrad. Med. 88(3): 217-224 (1990)
124. Levitz, S.M.: Aspergiliosis. Infect. Dis. Clin North Am. 3: 1-18 (1989)
125. Kovacs, J.A.: Diagnosis, treatment and preven­tion of pneumonocystis carinii pneumonia in HIV-in­fected patients. AIDS Update 2: 1-12 (1989)
126. Kovacs, J.A.: Are corticosteroids beneficial as adjuctive therapy for pneumonocystis pneumonia in AIDS? Ann. Intern. Med. 113: 1-3 (1990)
127. National Institute of Health – University of Cali­fornia Expert Panel for Corticosteroids as Adjuctive Therapy for Pneumonocystis Pneumonia. Consensus statement of the use of corticosteroids as adjuctive therapy for pneumonocystis pneumonia in the ac­quired immunodeficiency syndrome. N. Engl. J. Med. 323: 1500-1504 (1990)
128. Montanar, J.S.G., Lawson, L.M., Levitt, N., Bel­zeberg, A., Schechter, M.T., Rueby, J.: Corticoster­oids prevent early deterioration in patients with mod­erately severe pneumonocystis pneumonia and the acquired Immunodeficiency syndrome. Ann. Intern. Med. 113: 14-20 (1990)
129. Rahal, J.J.: Corticosteroid as adjuctive therapy for pneumonocystis pneumonia in patients with AIDS. N. Engl. J. Med. 324: 1666 (1991)
130. Jung, T.T.K., Rhee, C.K.: Diagnosis and man­agement of otitis media. Otolaryngol. Clin. North Am. 930: 45 (1992)
131. Schwartz, R.H., Puglese, J., Schwartz, D.M.: Use of a short course of prednisone for treating middle ear effusion: A double-blind crossover study. Ann. Otol. Rhinol. Laryngol. 68: 296-299 (1980)
132. Niederman, L.G., Walker-Buchlotz, Jabalay, T.: A comparative trial of steroid versus placebos for treatment of chronic otitis media with effusion. In: Recent Advances in Obitis Media with Effusion (D.J. Lim, C.D. Bluestone, J.O. Klein, J.D. Nelson, eds) pp. 273-276, Marcel Decker, Philadelphia, 1984
133. Macknin, M.L., Jones, P.K.: Oral dex­amethasone for treatment of persistent middle ear effusion. Pediatrics 75: 329-335 (1985)
134. Giebink, G.S., Batalden, P.B., Le, C.T., Lass­man, F.M., Buran, D.J., Seltz, A.E.: Controlled trial comparing the treatment for chronic otitis with effu­sion. Pediatr. Infect. Dis. J. 9: 33-37 (1990)
135. Podoshin, L., Fradis, M., Ben-David, V., Faraggi, D.: The efficacy of oral steroids in the treatment of persistent otitis media with effusion. Arch. Otolaryn­gol. Head Neck Surg. 116: 1404-1406 (1990)
136. Kaplan, K.: Brain abscess. Med. Clin. North Am. 69: 345-360 (1985)
137. Scheld, W.M., Brodeur, J.P.: Effect of methyl­prednisolone on entry of ampicillin and gentamicin into the cerebrospinal fluid n experimental pneu­monococcal and E. coli meningitis. Antimicrob. Che­mother. 11: 245-249 (1983)
138. Wispelwey, B., Scheld, W.M.: Brain abscess: Etiology, diagnosis and treatment. Infect. Med. 7(Dec.): 17-27 (1990)
139. Mampalam, T.J., Rosenblum, M.L.: Trends in the management of bacterial bran abscesses: a re­view of 102 cases over 17 years. Neurosurgery 23: 452-458 (1988)
140. Mabey, B.E., Walls, R.M.: Acute pericarditis. J. Emerg. Med. 3: 457-467 (1985)
141. Blum, A.I., Stutz, R., Haemmerli, U.P., Schmid, P., Grady, G.F.: A fortuitously controlled study of steroid therapy in acute viral hepatitis. I: Acute dis­ease. Am. J. Med. 47: 82-92 (1969)
142. Gregory, P.B., Knauer, C.M., Kempson, R.L., Miller, R.: Steroid therapy in severe viral hepatitis. N. Engl. J. Med. 294: 681-687 (1971)
143. Cook, G.C., Mulligan, R., Sherlock, S.: Con­trolled prospective trial of corticosteroid therapy in active chronic hepatitis. Q. J. Med. 40: 159-166 (1971)
144. Soloway, R.D., Summerskill, W.H.J., Baggen­stos, A.H.: Clinical, biochemical and histological re­mission of severe chronic active liver disease: A con­trolled trial of treatment and early prognosis. Gas­troenterology 63: 820-825 (1972)
145. Murray-Lyon, I.M., Sten, R.B.M Williams, R.: Controlled trial of prednisolone and azathioprine in active chronic hepatitis. Lancet 1: 735-737 (1973)
146. Lam, K.C., Lai, C.L., Trepo, C., Wu, P.C.: Dele­terious effect of prednosolone in HbsAg-positive chronic active hepatitis. N. Engl. J. Med. 304: 380-386 (1981)
147. Sagnelli, E., Mazillo, G., Maio, G.: Serun levels of hepatitis B surface and core antigens during im­munosuppressive treatment of HbsAg-positive chronic active hepatitis. Lancet 2: 395-397 (1980)
148. Hoofnagle, J.H., Davis, G.I., Pappas, C., Han­son, R.G., Peters, M., Avigan, M.I., Waggoner, J.G., Jones, A., Seeff, L.B.: A short course of predni­solone in chronic active hepatitis. Report of a ran­domized double-blind, placebo controlled trial. Ann. Intern. Med. 104: 12-17 (1986)
149. Gregory, P.B.: Treatment of chronic viral hepa­titis. In: Viral Hepatitis and Liver Disease (G.N. Vyas, J.L. Diestag, J.H. Hoofnagle, eds), pp. 126-134, Grune and Stratton, New York, 1984
150. Nair, P.V., Tong, M.J., Stevenson, D.: A pilot study on the effects of prednisone withdrawal on se­rum hepatitis B virus DNA and HbsAg in chronic ac­tive hepatitis. Hepatology 6: 1319-1324 (1986)
151. Leibowitz, H.M., Kupferman, A.: Antiinflamma­tory medications. Int. Ophthalmol. Clin. 20: 117-129 (1980)
152. Leibowitz, H.M.: Management of inflammation n the cornea and conjuctiva. Ophthalmology 87: 753-758 (1980)
153. Friedlaender, M.H.: Corticosteroid therapy of ocular inflammation. Int. Ophthalmol. Clin. 23: 175 (1983)
154. Roberts, A.M., Leibowitz, H.M.: Corticosteroid therapy of ophthalmologic diseases. Hosp. Pract. (Febr.): 181-196 (1984)
155. Dretler, R.H., Ransher, D.B.: Giant esophageal ulcer healed with a steroid therapy in an AIDS pa­tient. Rev. Infect. Dis. 11: 768-768 (1989)
156. Kotler, D.P., Peka, S., Borcich, A., Winkler, W.P.: Corticosteroid therapy for idiopathic esopha­geal ulcer in AIDS. Gastrointest. Endosc. 36: 191-192 (1990)
157. Levine, M.S., Loercher, G., Katzka, D.A., Her­linger, H., Rubesin, S.E., Laufer, I.: Giant human immunodeficiency virus-related ulcers in the esopha­gus. Radiology 180: 323-326 (1991)
158. Wilcox, C.M., Schwartz, D.A.: A pilot study or oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection. Am. J. Med. 93: 131-134 (1992)